Please assess the completion status of the following clinical trial:

Trial Title: Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Soft tissue sarcoma histology~* Tumor size \>= 5 cm~* Deep/extracompartimental localization~* Grade 2/3 (FNCLCC)~* Patients with inadequate previous therapy~* Age 18-65 years~* normal bone marrow function~* normal liver function~* normal renal function~* Karnofsky index \>=80%~Exclusion Criteria:~* Chordoma~* Chondrosarcoma~* Kaposi´ sarcoma~* Neuroblastoma~* Mesothelioma~* Osteosarcoma/Ewings´sarcoma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Treatment Arm (Type: EXPERIMENTAL): All patients receive 4 cycles of EIA chemotherapy pre- and postoperatively. There is no further observation arm. The study is non-randomized.

Based on this trial design, predict the completion outcome and termination type (if applicable).